Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055471
Status:
COMPLETED
Last Update Posted:
2012-10-31
First Post:
2003-03-03
Brief Title:
A Phase IIa Open-label Multicenter Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 Zibotentan Given Orally Once Daily in Subjects With Metastatic Prostate Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06
Start Date Type:
None
Primary Completion Date:
2005-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-10
Completion Date Type:
ACTUAL
First Submit Date:
2003-03-03
First Submit QC Date:
March 3 2003
Study First Post Date:
2003-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-08-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-10-23
Last Update Post Date:
2012-10-31
Last Update Post Date Type:
ESTIMATED